Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

RxSight (RXST) Leases (2020 - 2025)

RxSight (RXST) has disclosed Leases for 6 consecutive years, with $10.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 11.22% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2025, down 11.22%, and an annual FY2025 reading of $10.0 million, down 11.22% over the prior year.
  • Leases was $10.0 million for Q4 2025 at RxSight, down from $10.3 million in the prior quarter.
  • Across five years, Leases topped out at $11.2 million in Q4 2024 and bottomed at $2.1 million in Q1 2024.
  • Average Leases over 5 years is $6.3 million, with a median of $4.6 million recorded in 2021.
  • The sharpest move saw Leases tumbled 42.28% in 2024, then skyrocketed 432.26% in 2025.
  • Year by year, Leases stood at $4.3 million in 2021, then dropped by 7.96% to $3.9 million in 2022, then tumbled by 38.02% to $2.4 million in 2023, then skyrocketed by 358.96% to $11.2 million in 2024, then decreased by 11.22% to $10.0 million in 2025.
  • Business Quant data shows Leases for RXST at $10.0 million in Q4 2025, $10.3 million in Q3 2025, and $10.6 million in Q2 2025.